Skip to main content

Scripps Florida to Use GenoLogics Platform for Proteomics, Systems Bio Research

NEW YORK, Feb. 8 (GenomeWeb News) - Scripps Florida will use GenoLogics' lab- and data-management system in its proteomics and systems biology research, GenoLogics said today.

 

According to GeneLogics, Scripps Florida, a 2-year-old extension of the La Jolla, Calif.-based Scripps Research Institute, is focused on biomedical research, technology development, and drug design.

 

Its proteomics program focuses on developing and applying advanced technologies in mass spectrometry-based proteomics to answer questions on how proteins are modified by cells in certain diseases, GenoLogics said.

 

Nick Tsinoremas, senior director and head of informatics at Scripps Florida, said the center decided to work with GeneLogics because it wanted "a system that can cross over with other discipline areas, such as genotyping, microarray and gene expression."

 

Financial details were not discussed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.